Celldex Therapeutics
CLDX
#4954
Rank
โ‚น116.17 B
Marketcap
โ‚น1,750
Share price
-4.87%
Change (1 day)
-53.38%
Change (1 year)

Operating Margin for Celldex Therapeutics (CLDX)

Operating Margin as of March 2025 (TTM): -2,248.76%

According to Celldex Therapeutics's latest financial reports and stock price the company's current Operating Margin is -2,248.76%. At the end of 2024 the company had an Operating Margin of -2,248.76%.

Operating Margin history for Celldex Therapeutics from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-2,248.76%9.44%
2023-2,054.76%-56.88%
2022-4,765.59%213.34%
2021-1,520.92%85.11%
2020-821.61%-42.3%
2019-1,423.96%-10.62%
2018-1,593.09%73.05%
2017-920.61%-51.39%
2016-1,894.05%-18.4%
2015-2,321.11%-29.51%
2014-3,292.81%65.99%
2013-1,983.70%275.85%
2012-527.79%9.15%
2011-483.53%8832.41%
2010-5.41%-97.78%
2009-244.10%-61.69%
2008-637.08%-58.85%
2007-1,548.01%-31.28%
2006-2,252.48%268.75%
2005-610.85%208.45%
2004-198.03%-21.81%
2003-253.27%17.67%
2002-215.25%-70.68%
2001-734.07%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-30.69%-98.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-164.69%-92.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-14.09%-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
13.78%-100.61%๐Ÿ‡บ๐Ÿ‡ธ USA
12.60%-100.56%๐Ÿ‡บ๐Ÿ‡ธ USA
13.12%-100.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
-556,900.00% 24,664.76%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.